Showing results (2651-2660 of 3,349) with videos related to

Sort By:
Pageof 335
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 23, 2025
Neoadjuvant trastuzumab deruxtecan alone or followed by paclitaxel, trastuzumab, and pertuzumab for high-risk HER2-positive early breast cancer (DESTINY-Breast11): a randomised, open-label, multicentre, phase III trialN Harbeck, S Modi, L Pusztai, et al.
Nature Communications|June 18, 2024
Repeat controlled human Plasmodium falciparum infections delay bloodstream patency and reduce symptomsPatricia Ferrer, Andrea A Berry, Allison N Bucsan, et al.
Journal of Hepatology|June 8, 2023
Evaluation of RNAi therapeutics VIR-2218 and ALN-HBV for chronic hepatitis B: Results from randomized clinical trialsEd Gane, Young-Suk Lim, Jae B Kim, et al.
Eclinicalmedicine|August 5, 2022
PfSPZ-CVac malaria vaccine demonstrates safety among malaria-experienced adults: A randomized, controlled phase 1 trialDrissa Coulibaly, Abdoulaye K Kone, Karim Traore, et al.
British Journal of Cancer|December 21, 2019
Drug responses are conserved across patient-derived xenograft models of melanoma leading to identification of novel drug combination therapiesRyan J Ice, Michelle Chen, Max Sidorov, et al.
Cancer|November 2, 2018
Phase 1 study of the combination of vemurafenib, carboplatin, and paclitaxel in patients with BRAF-mutated melanoma and other advanced malignanciesMinny Bhatty, Shumei Kato, Sarina A Piha-Paul, et al.
Journal of Materials Science. Materials in Medicine|February 11, 2015
A unified in vitro evaluation for apatite-forming ability of bioactive glasses and their variantsAnthony L B Maçon, Taek B Kim, Esther M Valliant, et al.
Nature Communications|December 15, 2018
All-optical structuring of laser-driven proton beam profilesLieselotte Obst-Huebl, Tim Ziegler, Florian-Emanuel Brack, et al.
ESMO Open|January 1, 2022
Pembrolizumab versus chemotherapy for patients with esophageal squamous cell carcinoma enrolled in the randomized KEYNOTE-181 trial in AsiaY Cao, S Qin, S Luo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 21, 2013
A multicenter, phase II trial of everolimus in locally advanced or metastatic thyroid cancer of all histologic subtypesS M Lim, H Chang, M J Yoon, et al.
Pageof 335